These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 6951825

  • 21. Antitumor agents from bohemic acid complex, III. The isolation of marcellomycin, musettamycin, rudolphomycin, mimimycin, collinemycin, alcindoromycin, and bohemamine.
    Nettleton DE, Balitz DM, Doyle TW, Bradner WT, Johnson DL, O'Herron FA, Schreiber RH, Coon AB, Moseley JE, Myllymaki RW.
    J Nat Prod; 1980; 43(2):242-58. PubMed ID: 7381507
    [Abstract] [Full Text] [Related]

  • 22. New antitumor antibiotics: 13-methylaclacinomycin A and its derivatives.
    Soga K, Furusho H, Mori S, Oki T.
    J Antibiot (Tokyo); 1981 Jun; 34(6):770-3. PubMed ID: 6944303
    [No Abstract] [Full Text] [Related]

  • 23. Microbial conversion of epsilon-pyrromycinone and epsilon-isorhodomycinone to 1-hydroxy-13-dihydrodaunomcyin and N-formyl-1-hydroxy-13-dihydrodaunomycin and their bioactivities.
    Yoshimoto A, Matsuzawa Y, Oki T, Naganawa H, Takeuchi T, Umezawa H.
    J Antibiot (Tokyo); 1980 Oct; 33(10):1150-7. PubMed ID: 7451366
    [Abstract] [Full Text] [Related]

  • 24. 13-Deoxycarminomycin, a new biosynthetic anthracycline.
    Cassinelli G, Forenza S, Rivola G, Arcamone F, Grein A, Merli S, Casazza AM.
    J Nat Prod; 1985 Oct; 48(3):435-9. PubMed ID: 3861771
    [Abstract] [Full Text] [Related]

  • 25. [Anthracycline antibiotics from genetically modified streptomycetes. The isolation, spectroscopic structural elucidation and biologic effects of beta-rhodomycin I].
    Ihn W, Schlegel B, Fleck WF, Tresselt D, Gutsche W, Sedmera P, Vokoun J.
    Pharmazie; 1984 Mar; 39(3):176-80. PubMed ID: 6427794
    [Abstract] [Full Text] [Related]

  • 26. New anthracycline antibiotic, 2-hydroxyaclacinomycin A.
    Oki T, Yoshimoto A, Matsuzawa Y, Takeuchi T, Umezawa H.
    J Antibiot (Tokyo); 1981 Jul; 34(7):916-8. PubMed ID: 6945302
    [No Abstract] [Full Text] [Related]

  • 27. Production of new anthracycline antibiotics 1-hydroxy-oxaunomycin and 6-deoxyoxaunomycin by limited biosynthetic conversion using a daunorubicin-negative mutant.
    Yoshimoto A, Johdo O, Tone H, Okamoto R, Naganawa H, Sawa T, Takeuchi T.
    J Antibiot (Tokyo); 1992 Oct; 45(10):1609-17. PubMed ID: 1473988
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Anthracycline metabolites from Streptomyces violaceus A262. IV. New anthracycline yellamycins produced by a variant strain SC-7.
    Johdo O, Tone H, Okamoto R, Yoshimoto A, Naganawa H, Sawa T, Takeuchi T.
    J Antibiot (Tokyo); 1991 Oct; 44(10):1155-9. PubMed ID: 1955397
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Anthracycline metabolites from Streptomyces violaceus A262. V. New anthracycline alldimycin A: a minor component isolated from obelmycin beer.
    Johdo O, Tone H, Okamoto R, Yoshimoto A, Naganawa H, Sawa T, Takeuchi T.
    J Antibiot (Tokyo); 1991 Oct; 44(10):1160-4. PubMed ID: 1955398
    [No Abstract] [Full Text] [Related]

  • 33. New aureolic acid antibiotics. I. Screening, isolation, characterization and biological properties.
    Koenuma M, Uchida N, Yamaguchi K, Kawamura Y, Matsumoto K.
    J Antibiot (Tokyo); 1988 Jan; 41(1):45-52. PubMed ID: 3346192
    [Abstract] [Full Text] [Related]

  • 34. Balmoralmycin, a new angucyclinone, and two related biosynthetic shunt products containing a novel ring system.
    Bindseil KU, Hug P, Peter HH, Petersen F, Roggo BE.
    J Antibiot (Tokyo); 1995 Jun; 48(6):457-61. PubMed ID: 7622429
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Anthracycline metabolites from Streptomyces violaceus A262. II. New anthracycline epelmycins produced by a blocked mutant strain SU2-730.
    Johdo O, Watanabe Y, Ishikura T, Yoshimoto A, Naganawa H, Sawa T, Takeuchi T.
    J Antibiot (Tokyo); 1991 Oct; 44(10):1121-9. PubMed ID: 1955395
    [Abstract] [Full Text] [Related]

  • 37. Biosynthesis of anthracycline antibiotics by Streptomyces galilaeus. II. Structure of new anthracycline antibiotics obtained by microbial glycosidation and biological activity.
    Matsuzawa Y, Yoshimoto A, Oki T, Naganawa H, Takeuchi T, Umezawa H.
    J Antibiot (Tokyo); 1980 Nov; 33(11):1341-7. PubMed ID: 6941953
    [Abstract] [Full Text] [Related]

  • 38. Anthracycline metabolites from Streptomyces violaceus A262. III. New anthracycline obelmycins produced by a variant strain SE2-2385.
    Johdo O, Watanabe Y, Ishikura T, Yoshimoto A, Naganawa H, Sawa T, Takeuchi T.
    J Antibiot (Tokyo); 1991 Oct; 44(10):1130-40. PubMed ID: 1955396
    [Abstract] [Full Text] [Related]

  • 39. Isolation of new anthracycline antibiotics, A447 C and D.
    Shimosaka A, Hayakawa Y, Nakagawa M, Furihata K, Seto H, Otake N.
    J Antibiot (Tokyo); 1987 Jan; 40(1):116-21. PubMed ID: 3558112
    [No Abstract] [Full Text] [Related]

  • 40. PD 124,895 and PD 124,966, two new antitumor antibiotics.
    Hurley TR, Bunge RH, Willmer NE, Hokanson GC, French JC.
    J Antibiot (Tokyo); 1986 Dec; 39(12):1651-6. PubMed ID: 3818438
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.